Navneet Majhail, MD
Director, Blood & Marrow Transplant Program, @ClevelandClinic | President, Am Soc Transplant Cell Therapy (@ASTCT) | #BMTsm #CARTcell #Celltherapy | Own opinion
Last synced from Twitter 20m ago
As medical schools diversify, they're learning hard lessons along the way
After schools were threatened with losing their accreditation if they didn't diversify, many made progress — and learned it's about more than numbers.
Navneet Majhail, MD
Medical schools are starting to diversify. But they’re learning hard lessons along the way statnews.com/2019/06/17/med… via @statnews
11h
Can Women With CML Safely Continue TKIs During Pregnancy?
Can Women With CML Safely Continue TKIs During Pregnancy? - Chronic Leukemias, On Location, Other Meetings - ASH Clinical News
Dr. Henry Lynch, 91, Dies; Found Hereditary Link in Cancer
To a doubting medical world, he found compelling evidence that some cancers are passed along genetically. His work was ultimately widely embraced.
Life Lessons from My Father
Father’s Day is a day to honor dads and the father figures in our lives. For me, it is also a day to reflect with gratitude on the many life lessons I’ve learned from my father.
Sticker shock: Bluebird bio sets a $1.8M European price on its newly approved gene therapy
Bluebird bio $BLUE has unveiled its price for the newly approved gene therapy Zynteglo (LentiGlobin), and it’s likely going to come as a surprise. With some analysts betting on a $900,000 price for the β-thalassemia treatment in Europe, where...
1
Navneet Majhail, MD
Sticker shock: Bluebird bio sets a $1.8M European price on its newly approved gene therapy
4d
The Arc of Therapy: From Cure to Humbling Legacy
Navneet Majhail, MD
"Awareness of long-term consequences, the concept of survivorship, and the concept of shared decision making are but a few of the inflections in the arc of therapy." The Arc of Therapy: From Cure to Humbling Legacy
4d
Special report: Summary of the first meeting of African Blood and Marrow Transplantation (AfBMT) group, Casablanca, Morocco, April 19–21, 2018 held under the auspices of the Worldwide Network for Blood and Marrow Transplantation (WBMT)
The first meeting of the African Blood and Marrow Transplantation (AfBMT) was held in Casablanca from April 19, 2018 to April 21, 2018, with the aim o…
A Judge Rules Against One Stem-Cell Clinic. There Are Hundreds of Them.
In a long-sought victory for the F.D.A., a federal judge said officials have the authority to regulate stem-cell treatments made from patients’ own fat.
How to Overcome ‘Impostor Syndrome’
It’s that nagging feeling that you don’t belong, and it affects women and minorities disproportionately. Here’s how to combat it.
1
Navneet Majhail, MD
🗣️ to @ASH_hematology #ASHCRTI small group 🙏 @tanyawildes @BiostatGirl @SurbhiSidanaMD @MelissaLoh21 @nbhattmd
8d
Medical misinformation and the internet: a call to arms
Almost 16 years ago my family and I were deposited on the other side of the stethoscope.
Pregnant with triplets, my membranes ruptured at almost 23 weeks and I delivered my
first son who I elected not to resuscitate. I managed to stay pregnant until...
Going Home: Acts of Presence and the Essence of Doctoring
In this narrative medicine essay a physician beginning her internship recalls what she learned from her grandfather in his life as a surgical oncologist and in his final illness, recognizing that the essence of doctoring lies in being present with...
Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond
Considering the unique curative potential of hematopoietic cell transplantation (HCT)
for many diseases and the considerable differences in activities worldwide, there
is a global need to expand access, especially in regions with constrained...
1
Navneet Majhail, MD
Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing #BMT Program, Part I: Minimum Requirements and Beyond by @mpasca @maljurf100 @Phari @shahrukhhashmi @marrow et al #bmtsm #BBMT
8d
Who is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidenitcal Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?
Hematopoietic stem cell transplantation (HCT) is a potentially curative therapy for
patients with life-threatening hematologic malignancies [1]. More than 20,000 HCT
are performed each year in the United States [2]. This number is predicted to...
The Business of Health Care Depends on Exploiting Doctors and Nurses
One resource seems infinite and free: the professionalism of caregivers.
1
Navneet Majhail, MD
"But one resource that seems endless — and free — is the professional ethic of medical staff members" The Business of Health Care Depends on Exploiting Doctors and Nurses
9d
OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OVER 69 YEARS OF AGE WITH ACUTE MYELOID LEUKEMIA: ON BEHALF OF THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT
Allogeneic hematopoietic stem cell transplantation (HSCT) may cure acute myeloid leukemia
(AML) [1–3]. The incidence of AML increases with age [4]. Age is important for survival
following HSCT and younger patients generally do better with lower...
Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
PURPOSE In patients with diffuse large B-cell lymphoma (DLBCL), most relapses occur within the first 2 years of diagnosis. We sought to define the rate and outcome of late relapses that occurred after achieving event-free survival at 24 months...
Cleveland Clinic targets time to treat in cancer
CHICAGO – The Taussig Cancer Institute at the Cleveland Clinic reduced the time to treat for newly diagnosed cancer patients by 33%. Taussig’s chairman, Dr. Brian Bolwell, said he wants to go even lower.
Aging has been very good for business. But can we honestly say business been good for aging?
Private markets see significant opportunity in supporting Americans through their senior years, but from a human perspective, the business of aging too often falls short of delivering solutions that meet fundamental societal needs.
BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma
High-dose chemotherapy followed by autologous hematopoietic stem cell transplant (AHSCT) is a standard of care for patients with relapsed Hodgkin lymp…
1
Navneet Majhail, MD
Better PFS and OS with BEAM in our 2 center comparative study:
BEAM versus BUCYVP16 before Autologous #BMT in Hodgkin Lymphoma #BMTsm #Lymsm #BBMT #CleClinicCancer
10d